Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[In addition to mutations in genes known to be involved in leukemogenesis (ETV6, NOTCH1, JAK1, and NF1), we identified novel recurrent mutations in FAT1 (25%), FAT3 (20%), DNM2 (35%), and genes associated with epigenetic regulation (MLL2, BMI1, and DNMT3A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP650962.RAhwbwKlUNFgXqBwUhOAEUWrfPVELbS3kHvDXBiiMVJso130_assertion description "[In addition to mutations in genes known to be involved in leukemogenesis (ETV6, NOTCH1, JAK1, and NF1), we identified novel recurrent mutations in FAT1 (25%), FAT3 (20%), DNM2 (35%), and genes associated with epigenetic regulation (MLL2, BMI1, and DNMT3A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP650962.RAhwbwKlUNFgXqBwUhOAEUWrfPVELbS3kHvDXBiiMVJso130_provenance.
• NP889701.RAbObhLn37HcViV3brlNmkYUzZB10bM3BlR48Hnrk3U9A130_assertion description "[In addition to mutations in genes known to be involved in leukemogenesis (ETV6, NOTCH1, JAK1, and NF1), we identified novel recurrent mutations in FAT1 (25%), FAT3 (20%), DNM2 (35%), and genes associated with epigenetic regulation (MLL2, BMI1, and DNMT3A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP889701.RAbObhLn37HcViV3brlNmkYUzZB10bM3BlR48Hnrk3U9A130_provenance.
• NP452331.RAr09WyJaKJng792A-2epIQ6yhmgmrydUMo484aMpksjw130_assertion description "[In addition to mutations in genes known to be involved in leukemogenesis (ETV6, NOTCH1, JAK1, and NF1), we identified novel recurrent mutations in FAT1 (25%), FAT3 (20%), DNM2 (35%), and genes associated with epigenetic regulation (MLL2, BMI1, and DNMT3A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP452331.RAr09WyJaKJng792A-2epIQ6yhmgmrydUMo484aMpksjw130_provenance.
• NP577536.RAhrPr1-JExI5wWpSbVv5gtFqtqD4qS8LV6dW3v5XxBJU130_assertion description "[In addition to mutations in genes known to be involved in leukemogenesis (ETV6, NOTCH1, JAK1, and NF1), we identified novel recurrent mutations in FAT1 (25%), FAT3 (20%), DNM2 (35%), and genes associated with epigenetic regulation (MLL2, BMI1, and DNMT3A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP577536.RAhrPr1-JExI5wWpSbVv5gtFqtqD4qS8LV6dW3v5XxBJU130_provenance.
• NP739117.RAtF0_KOm2i37MOUpCRSwwALLdWW7G6zvs8Y_V5bcYMC4130_assertion description "[In addition to mutations in genes known to be involved in leukemogenesis (ETV6, NOTCH1, JAK1, and NF1), we identified novel recurrent mutations in FAT1 (25%), FAT3 (20%), DNM2 (35%), and genes associated with epigenetic regulation (MLL2, BMI1, and DNMT3A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP739117.RAtF0_KOm2i37MOUpCRSwwALLdWW7G6zvs8Y_V5bcYMC4130_provenance.
• assertion description "[In addition to mutations in genes known to be involved in leukemogenesis (ETV6, NOTCH1, JAK1, and NF1), we identified novel recurrent mutations in FAT1 (25%), FAT3 (20%), DNM2 (35%), and genes associated with epigenetic regulation (MLL2, BMI1, and DNMT3A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP461673.RAQ2Kfk8O7PSA3BUNkaU_ONNpyKESY8f0-6-MAELtwemM130_assertion description "[In addition to mutations in genes known to be involved in leukemogenesis (ETV6, NOTCH1, JAK1, and NF1), we identified novel recurrent mutations in FAT1 (25%), FAT3 (20%), DNM2 (35%), and genes associated with epigenetic regulation (MLL2, BMI1, and DNMT3A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP461673.RAQ2Kfk8O7PSA3BUNkaU_ONNpyKESY8f0-6-MAELtwemM130_provenance.
• NP448952.RA02licLh2CyFBhgbpJcK6Vf2qsMuxdGEzpykwcRgChUo130_assertion description "[In addition to mutations in genes known to be involved in leukemogenesis (ETV6, NOTCH1, JAK1, and NF1), we identified novel recurrent mutations in FAT1 (25%), FAT3 (20%), DNM2 (35%), and genes associated with epigenetic regulation (MLL2, BMI1, and DNMT3A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP448952.RA02licLh2CyFBhgbpJcK6Vf2qsMuxdGEzpykwcRgChUo130_provenance.
• NP198590.RA6f0FoKlS_O0KCUsvgHGj2_PxK0RXCh2o799yeT9B2lc130_assertion description "[In addition to mutations in genes known to be involved in leukemogenesis (ETV6, NOTCH1, JAK1, and NF1), we identified novel recurrent mutations in FAT1 (25%), FAT3 (20%), DNM2 (35%), and genes associated with epigenetic regulation (MLL2, BMI1, and DNMT3A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP198590.RA6f0FoKlS_O0KCUsvgHGj2_PxK0RXCh2o799yeT9B2lc130_provenance.
• assertion description "[In addition to mutations in genes known to be involved in leukemogenesis (ETV6, NOTCH1, JAK1, and NF1), we identified novel recurrent mutations in FAT1 (25%), FAT3 (20%), DNM2 (35%), and genes associated with epigenetic regulation (MLL2, BMI1, and DNMT3A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In addition to mutations in genes known to be involved in leukemogenesis (ETV6, NOTCH1, JAK1, and NF1), we identified novel recurrent mutations in FAT1 (25%), FAT3 (20%), DNM2 (35%), and genes associated with epigenetic regulation (MLL2, BMI1, and DNMT3A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In addition to mutations in genes known to be involved in leukemogenesis (ETV6, NOTCH1, JAK1, and NF1), we identified novel recurrent mutations in FAT1 (25%), FAT3 (20%), DNM2 (35%), and genes associated with epigenetic regulation (MLL2, BMI1, and DNMT3A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP609740.RA0FQSEfIudsWizW1R2tkxBEXaaLU3cVd_zTG2qFI9oJk130_assertion description "[In addition to mutations in genes known to be involved in leukemogenesis (ETV6, NOTCH1, JAK1, and NF1), we identified novel recurrent mutations in FAT1 (25%), FAT3 (20%), DNM2 (35%), and genes associated with epigenetic regulation (MLL2, BMI1, and DNMT3A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP609740.RA0FQSEfIudsWizW1R2tkxBEXaaLU3cVd_zTG2qFI9oJk130_provenance.
• NP734185.RAy-pqTEFERsmYTMvNKXQU6QRFNGXj7D3S22boYdDrPw4130_assertion description "[In addition to mutations in genes known to be involved in leukemogenesis (ETV6, NOTCH1, JAK1, and NF1), we identified novel recurrent mutations in FAT1 (25%), FAT3 (20%), DNM2 (35%), and genes associated with epigenetic regulation (MLL2, BMI1, and DNMT3A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP734185.RAy-pqTEFERsmYTMvNKXQU6QRFNGXj7D3S22boYdDrPw4130_provenance.
• NP357795.RAf2oqOVEzhzJ_F3ynGVFlr18rk5zgKjF6qYVAhzITnn0130_assertion description "[In addition to mutations in genes known to be involved in leukemogenesis (ETV6, NOTCH1, JAK1, and NF1), we identified novel recurrent mutations in FAT1 (25%), FAT3 (20%), DNM2 (35%), and genes associated with epigenetic regulation (MLL2, BMI1, and DNMT3A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP357795.RAf2oqOVEzhzJ_F3ynGVFlr18rk5zgKjF6qYVAhzITnn0130_provenance.
• NP638053.RA2tzXhab8GPOr7E2JFUXEVg6Ef7jgJj1BPYGCJ2Ax8v8130_assertion description "[In addition to mutations in genes known to be involved in leukemogenesis (ETV6, NOTCH1, JAK1, and NF1), we identified novel recurrent mutations in FAT1 (25%), FAT3 (20%), DNM2 (35%), and genes associated with epigenetic regulation (MLL2, BMI1, and DNMT3A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP638053.RA2tzXhab8GPOr7E2JFUXEVg6Ef7jgJj1BPYGCJ2Ax8v8130_provenance.
• NP387335.RAWsE4K6C3g38fiSJKQvqAhYUPnngXQ2_vmHzh4MtiGlM130_assertion description "[In addition to mutations in genes known to be involved in leukemogenesis (ETV6, NOTCH1, JAK1, and NF1), we identified novel recurrent mutations in FAT1 (25%), FAT3 (20%), DNM2 (35%), and genes associated with epigenetic regulation (MLL2, BMI1, and DNMT3A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP387335.RAWsE4K6C3g38fiSJKQvqAhYUPnngXQ2_vmHzh4MtiGlM130_provenance.
• assertion description "[In addition to mutations in genes known to be involved in leukemogenesis (ETV6, NOTCH1, JAK1, and NF1), we identified novel recurrent mutations in FAT1 (25%), FAT3 (20%), DNM2 (35%), and genes associated with epigenetic regulation (MLL2, BMI1, and DNMT3A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP1071150.RACNmhrta3cOrxytHld2pTHnIJb1GFVHX_iz5Mpk9GxnM130_assertion description "[In addition to mutations in genes known to be involved in leukemogenesis (ETV6, NOTCH1, JAK1, and NF1), we identified novel recurrent mutations in FAT1 (25%), FAT3 (20%), DNM2 (35%), and genes associated with epigenetic regulation (MLL2, BMI1, and DNMT3A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1071150.RACNmhrta3cOrxytHld2pTHnIJb1GFVHX_iz5Mpk9GxnM130_provenance.
• NP1071151.RAcD5K6YepYx0PjgQ1SNw5SUpAlZrn4sZIJnPVEQrGJlg130_assertion description "[In addition to mutations in genes known to be involved in leukemogenesis (ETV6, NOTCH1, JAK1, and NF1), we identified novel recurrent mutations in FAT1 (25%), FAT3 (20%), DNM2 (35%), and genes associated with epigenetic regulation (MLL2, BMI1, and DNMT3A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1071151.RAcD5K6YepYx0PjgQ1SNw5SUpAlZrn4sZIJnPVEQrGJlg130_provenance.
• assertion description "[In addition to mutations in genes known to be involved in leukemogenesis (ETV6, NOTCH1, JAK1, and NF1), we identified novel recurrent mutations in FAT1 (25%), FAT3 (20%), DNM2 (35%), and genes associated with epigenetic regulation (MLL2, BMI1, and DNMT3A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP1071149.RAh8igxtTfzGw6jhzI4nR57hplDDR7Y6hIEIZvvt1WwZg130_assertion description "[In addition to mutations in genes known to be involved in leukemogenesis (ETV6, NOTCH1, JAK1, and NF1), we identified novel recurrent mutations in FAT1 (25%), FAT3 (20%), DNM2 (35%), and genes associated with epigenetic regulation (MLL2, BMI1, and DNMT3A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1071149.RAh8igxtTfzGw6jhzI4nR57hplDDR7Y6hIEIZvvt1WwZg130_provenance.
• NP519049.RA_bYUDfrDDUpQTKSiTXvs4304Rip4ikEaAhLn298QhsE130_assertion description "[In addition to mutations in genes known to be involved in leukemogenesis (ETV6, NOTCH1, JAK1, and NF1), we identified novel recurrent mutations in FAT1 (25%), FAT3 (20%), DNM2 (35%), and genes associated with epigenetic regulation (MLL2, BMI1, and DNMT3A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP519049.RA_bYUDfrDDUpQTKSiTXvs4304Rip4ikEaAhLn298QhsE130_provenance.